Since 1970, we are contributing to becoming a corporation in terms of health and happy future life through constant research development providing safe and effective medical products.Through the technical partnership with the advanced pharmaceutical companies of Europe and Japan, introduced "Cernilton" as a safe prostate cure of ingredient of medicinal herbs and " Ventrux" as active probiotic intestinal cure within a country. On the other hand, we devote ourselves on new medical products, improvement of new medicines, and first generic development based on the material technology ourselves.

We elevate the effectiveness of the drug as the development of external usage steroids introduced Multi Lamellar Emulsion (MLE), the reproduction technology of skin lipids structure and minimize the side-effect based on absorption of entire body.We build stable R&D pipeline for manufacturing the new medical products and development of regent improved through steady research, the development of improvement of new medicines changed the injection pathway, and the development of DDS product through the release controlling system, and SC development research base specialized based on improvement of non-soluble medicines. Major products are "Alastin Tab. (epinastine)", "Sponex cap. (itraconazole)", "Thermatasone MLE cream(Mometasone Furoate)", "Famclovir ( Famciclovir)", "Uropa tab. (Tamsulosin)" We propel the diversification of the business of the development of medical products, health functional foods ( Ethical foods etc), medical appliances (anti-snoring devices etc), cosmetic (using stem cells), bio-medical products development and etc based on the strong point of skin urology, otorhinolaryngology and expanding to internal medicine. In the future, Dongkoo Bio&Pharma. Co., Ltd. is becoming the leading company of the development of new medical products with all passion that contribute to national health, treatment of disease, and welfare based on the differentiated strategy and technology competitiveness.